Literature DB >> 19352209

Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.

Kiyohisa Kamimura1, Shigeki Nagamachi, Hideyuki Wakamatsu, Seigo Fujita, Ryuichi Nishii, Yoshiro Umemura, Mikio Ogita, Naoto Komada, Toshinori Sakurai, Teruhiko Inoue, Toshiro Fujimoto, Masayuki Nakajo.   

Abstract

PURPOSE: In this study, we investigated the role of gastric distention with additional water to determine whether it is beneficial for the differentiation of locally advanced gastric carcinomas from physiological 18F-fluoro-2-deoxy-D-glucose (FDG) uptake in the stomach and to characterize the FDG uptake of gastric carcinomas by relating it to the histopathological properties of the tumours.
METHODS: Sixteen patients with locally advanced gastric carcinomas and 20 control patients were studied by FDG-PET. After whole-body PET imaging, the patients drank 400 ml of water and then spot imaging with additional water of the stomach was performed. The final diagnosis was determined from the results of surgery. The gastric areas were divided into the upper, middle, and lower parts. The degree of FDG uptake in the stomach was qualitatively evaluated by visual grading into three degrees. For quantitative analysis, the regional tumour uptake was measured by mean standardized uptake values using a region of interest technique.
RESULTS: In visual analysis, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET without additional water ingestion were 100, 50, 62, 100 and 72%, respectively, and those of PET with additional water ingestion were 88, 100, 100, 91 and 94%, respectively. Using spot imaging under the condition with additional water ingestion, four gastric carcinomas were depicted more clearly.
CONCLUSION: Gastric distention as a result of patients drinking a glass of water is a simple and noninvasive method for improving the diagnostic accuracy of FDG-PET in patients with locally advanced gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352209     DOI: 10.1097/MNM.0b013e3283299a2f

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  13 in total

Review 1.  Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT.

Authors:  Mijin Yun
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

2.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

3.  Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.

Authors:  Jeonghun Kim; Seok Tae Lim; Chang Ju Na; Yeon-Hee Han; Chan-Young Kim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

Review 4.  Diagnosis and evaluation of gastric cancer by positron emission tomography.

Authors:  Chen-Xi Wu; Zhao-Hui Zhu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 5.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Authors:  Hideaki Shimada; Shinichi Okazumi; Masamichi Koyama; Koji Murakami
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

Review 6.  Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.

Authors:  Elizabeth C Smyth; Manish A Shah
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

7.  The role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancer.

Authors:  Kazim Duman; Abdurrahman Simsek; Semih Gorgulu; Gokhan Yagci; Yusuf Peker
Journal:  Eurasian J Med       Date:  2013-10

8.  Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.

Authors:  Kinga Grabinska; Maciej Pelak; Jerzy Wydmanski; Andrzej Tukiendorf; Andrea d'Amico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

9.  Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT.

Authors:  Hye Ryeong Kwon; Kisoo Pahk; Sungsoo Park; Hyun Woo Kwon; Sungeun Kim
Journal:  Nucl Med Mol Imaging       Date:  2019-11-18

10.  [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.

Authors:  Ryusuke Takebayashi; Kunihiko Izuishi; Yuka Yamamoto; Reiko Kameyama; Hirohito Mori; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.